Cargando…
Why Treatment Fails in Type 2 Diabetes
Erik Renström and colleagues discuss a new mouse study that explores the mechanism behind the secondary failure of sulfonylurea treatment.
Autores principales: | Rosengren, Anders, Jing, Xingjun, Eliasson, Lena, Renström, Erik |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573917/ https://www.ncbi.nlm.nih.gov/pubmed/18959474 http://dx.doi.org/10.1371/journal.pmed.0050215 |
Ejemplares similares
-
Why 90% of clinical drug development fails and how to improve it?
por: Sun, Duxin, et al.
Publicado: (2022) -
Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails
por: Yiangou, Loukia, et al.
Publicado: (2020) -
Mechanisms of drugs in the treatment of type 2 diabetes mellitus
por: Yang, Tao, et al.
Publicado: (2023) -
Designed to Fail? the Future of Primary Care
por: McMahon, Laurence F., et al.
Publicado: (2020) -
Molnupiravir: From Hope to Epic Fail?
por: Focosi, Daniele
Publicado: (2022)